|
Insider Trading: Genomic Health Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005.
The reporting company's ticker symbol is GHDX.
The reporting company's CIK number is 1131324.
The total value of stock buying since 2005 is $136,359,992.
The total value of stock sales is $7,583,655.
The total value of stock exercises is $43,801.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Genomic Health Inc (GHDX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Genomic Health Inc (GHDX) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Genomic Health Inc (GHDX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 55,927 | 1,330,898 | 5,000 | 6,650 |
| 2008-07 | 0 | 0 | 16,629 | 341,144 | 0 | 0 |
| 2008-06 | 493,611 | 9,797,003 | 16,729 | 324,300 | 0 | 0 |
| 2008-05 | 0 | 0 | 16,629 | 314,165 | 0 | 0 |
| 2008-04 | 0 | 0 | 12,000 | 206,661 | 0 | 0 |
| 2008-03 | 0 | 0 | 16,629 | 320,829 | 0 | 0 |
| 2008-02 | 0 | 0 | 30,629 | 686,749 | 10,201 | 9,649 |
| 2008-01 | 0 | 0 | 16,629 | 411,398 | 0 | 0 |
| 2007-12 | 0 | 0 | 4,629 | 106,909 | 0 | 0 |
| 2007-11 | 0 | 0 | 11,284 | 253,850 | 0 | 0 |
| 2007-10 | 0 | 0 | 16,629 | 333,780 | 0 | 0 |
| 2007-09 | 0 | 0 | 40,629 | 799,617 | 0 | 0 |
| 2007-08 | 5,350 | 100,390 | 16,629 | 328,863 | 0 | 0 |
| 2007-07 | 0 | 0 | 16,629 | 342,237 | 0 | 0 |
| 2007-06 | 0 | 0 | 16,629 | 311,135 | 0 | 0 |
| 2007-05 | 4,000,143 | 64,066,162 | 16,629 | 274,924 | 0 | 0 |
| 2007-04 | 0 | 0 | 16,629 | 286,651 | 43,345 | 27,502 |
| 2007-03 | 628,786 | 11,484,603 | 16,629 | 304,356 | 0 | 0 |
| 2007-02 | 811,781 | 14,845,329 | 16,629 | 305,189 | 0 | 0 |
| 2006-12 | 953,338 | 19,286,642 | 0 | 0 | 0 | 0 |
| 2006-09 | 1,195,954 | 16,779,863 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Genomic Health Inc (GHDX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-26 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 22.69 | 105,048 |
| 2008-08-26 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 22.93 | 114,673 |
| 2008-08-18 | Cole G Bradley (EVP & CFO) | Sale | 9,298 | 23.67 | 220,116 |
| 2008-08-18 | Cole G Bradley (EVP & CFO) | Option Exercise | 5,000 | 1.33 | 6,650 |
| 2008-08-15 | Popovits Kimberly J (President and COO) | Sale | 12,500 | 24.08 | 300,953 |
| 2008-08-14 | Popovits Kimberly J (President and COO) | Sale | 12,500 | 24.40 | 305,035 |
| 2008-08-12 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 23.93 | 143,590 |
| 2008-08-11 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 23.58 | 141,483 |
| 2008-07-15 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 21.19 | 127,167 |
| 2008-07-14 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 20.81 | 124,838 |
| 2008-07-01 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 19.26 | 89,139 |
| 2008-06-24 | Shak Steven (Chief Medical Officer) | Sale | 100 | 20.00 | 2,000 |
| 2008-06-10 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 19.83 | 118,972 |
| 2008-06-09 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 20.01 | 120,032 |
| 2008-06-09 | Baker Felix (Director) | Purchase | 82,618 | 19.64 | 1,622,935 |
| 2008-06-06 | Baker Felix (Director) | Purchase | 201,769 | 20.11 | 4,057,543 |
| 2008-06-05 | Baker Felix (Director) | Purchase | 122,910 | 19.55 | 2,403,399 |
| 2008-06-02 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 17.99 | 83,296 |
| 2008-05-13 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 18.69 | 112,111 |
| 2008-05-12 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 18.81 | 112,863 |
| 2008-05-08 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 19.27 | 89,191 |
| 2008-04-15 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 17.57 | 105,398 |
| 2008-04-14 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 16.88 | 101,263 |
| 2008-03-11 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 18.38 | 110,269 |
| 2008-03-10 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 19.29 | 115,757 |
| 2008-03-05 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 20.48 | 94,803 |
| 2008-02-26 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 20.23 | 101,159 |
| 2008-02-19 | Cohen Fred E (Director) | Option Exercise | 5,201 | .58 | 2,999 |
| 2008-02-19 | Cole G Bradley (EVP & CFO) | Sale | 9,000 | 22.58 | 203,263 |
| 2008-02-19 | Cole G Bradley (EVP & CFO) | Option Exercise | 5,000 | 1.33 | 6,650 |
| 2008-02-12 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 22.85 | 137,073 |
| 2008-02-11 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 23.17 | 139,045 |
| 2008-02-11 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 22.94 | 106,209 |
| 2008-01-15 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 26.20 | 157,182 |
| 2008-01-14 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 24.89 | 149,332 |
| 2008-01-02 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 22.66 | 104,884 |
| 2007-12-03 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 23.10 | 106,909 |
| 2007-11-27 | Popovits Kimberly J (President and COO) | Sale | 6,655 | 22.00 | 146,410 |
| 2007-11-08 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 23.21 | 107,440 |
| 2007-10-09 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 20.07 | 120,420 |
| 2007-10-08 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 20.25 | 121,500 |
| 2007-10-01 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 19.84 | 91,860 |
| 2007-09-11 | Scott Randal W (Chief Executive Officer) | Sale | 12,000 | 19.81 | 237,718 |
| 2007-09-10 | Scott Randal W (Chief Executive Officer) | Sale | 12,000 | 19.58 | 234,958 |
| 2007-09-10 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 19.57 | 90,603 |
| 2007-08-23 | Goldberg Michael D (Director) | Purchase | 5,350 | 18.76 | 100,390 |
| 2007-08-15 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 19.79 | 118,740 |
| 2007-08-14 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 20.02 | 120,120 |
| 2007-08-08 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 19.44 | 90,003 |
| 2007-07-18 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 21.20 | 127,200 |
| 2007-07-17 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 21.17 | 127,020 |
| 2007-07-02 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 19.01 | 88,017 |
| 2007-06-19 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 19.30 | 115,800 |
| 2007-06-18 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 19.01 | 114,060 |
| 2007-06-01 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 17.56 | 81,275 |
| 2007-05-30 | Baker Felix (Director) | Purchase | 18,577 | 16.45 | 305,616 |
| 2007-05-29 | Baker Felix (Director) | Purchase | 127,821 | 16.39 | 2,094,499 |
| 2007-05-25 | Baker Felix (Director) | Purchase | 156,234 | 16.24 | 2,537,910 |
| 2007-05-24 | Baker Felix (Director) | Purchase | 91,912 | 16.33 | 1,501,069 |
| 2007-05-23 | Baker Felix (Director) | Purchase | 98,314 | 16.40 | 1,612,495 |
| 2007-05-22 | Baker Felix (Director) | Purchase | 532,857 | 16.67 | 8,882,457 |
| 2007-05-21 | Baker Felix (Director) | Purchase | 979,313 | 15.50 | 15,179,350 |
| 2007-05-08 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 16.31 | 97,841 |
| 2007-05-08 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 16.31 | 75,512 |
| 2007-05-07 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 16.93 | 101,571 |
| 2007-04-30 | Popovits Kimberly J (President & COO) | Option Exercise | 43,345 | .63 | 27,502 |
| 2007-04-10 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 17.34 | 104,065 |
| 2007-04-09 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 17.20 | 103,170 |
| 2007-04-02 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 17.16 | 79,416 |
| 2007-03-09 | Baker Felix (Director) | Purchase | 239,817 | 18.35 | 4,402,863 |
| 2007-03-06 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 18.70 | 112,183 |
| 2007-03-05 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 18.00 | 107,995 |
| 2007-03-02 | Baker Julian (Director) | Purchase | 10,818 | 18.02 | 194,984 |
| 2007-03-01 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 18.18 | 84,178 |
| 2007-03-01 | Baker Julian (Director) | Purchase | 65,408 | 17.96 | 1,174,600 |
| 2007-02-21 | Myers Woodrow A Jr (Director) | Purchase | 2,000 | 19.63 | 39,260 |
| 2007-02-16 | Baker Julian (Director) | Purchase | 36,200 | 18.49 | 669,213 |
| 2007-02-14 | Baker Julian (Director) | Purchase | 100,200 | 18.39 | 1,843,171 |
| 2007-02-13 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 18.32 | 109,908 |
| 2007-02-13 | Baker Julian (Director) | Purchase | 237,838 | 18.26 | 4,342,325 |
| 2007-02-12 | Scott Randal W (Chief Executive Officer) | Sale | 6,000 | 17.91 | 107,475 |
| 2007-02-12 | Baker Julian (Director) | Purchase | 30,970 | 17.89 | 554,127 |
| 2007-02-08 | Baker Joffre (Chief Scientific Officer) | Sale | 4,629 | 18.97 | 87,806 |
| 2006-12-06 | Baker Julian (Director) | Purchase | 48,172 | 21.58 | 1,039,660 |
| 2006-12-05 | Myers Woodrow A Jr (Director) | Purchase | 10,000 | 21.97 | 219,700 |
| 2006-12-05 | Baker Julian (Director) | Purchase | 98,691 | 22.55 | 2,225,105 |
| 2006-12-04 | Baker Julian (Director) | Purchase | 47,158 | 20.58 | 970,600 |
| 2006-12-01 | Baker Julian (Director) | Purchase | 536,901 | 19.63 | 10,538,184 |
| 2006-09-08 | Baker Felix (Other) | Purchase | 535,600 | 14.14 | 7,575,766 |
| 2006-09-07 | Baker Felix (Other) | Purchase | 100,000 | 13.42 | 1,342,036 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Genomic Health Inc (symbol GHDX,
CIK number 1131324) see
the Securities and Exchange Commission (SEC) website.
|
|
